All Stories

  1. Enzyme replacement therapy in infants and very young children with Gaucher disease using velaglucerase alfa: a single-center experience

    Article • Frontiers in Pediatrics, October 2025, Frontiers

    Dr Margarita M Ivanova

  2. The clinical utility of neurofilament light chain for early detection and prediction of disease burden and severity in neuronopathic Gaucher disease

    Article • Molecular Genetics and Metabolism, August 2025, Elsevier

    Dr Margarita M Ivanova

  3. Age-related inflammatory biomarkers in early-onset osteoporosis in females with Gaucher disease

    Article • Frontiers in Endocrinology, July 2025, Frontiers

    Dr Margarita M Ivanova

  4. Sex Differences in Circulating Inflammatory, Immune, and Tissue Growth Markers Associated with Fabry Disease-Related Cardiomyopathy

    Article • Cells, February 2025, MDPI AG

    Dr Margarita M Ivanova

  5. Neuronopathic Gaucher disease: Rare in the West, common in the East

    Article • Journal of Inherited Metabolic Disease, May 2024, Wiley

    Dr Margarita M Ivanova

  6. The Expression and Secretion Profile of TRAP5 Isoforms in Gaucher Disease

    Article • Cells, April 2024, MDPI AG

    Dr Margarita M Ivanova

  7. Biofabrication of an in-vitro bone model for Gaucher disease

    Article • Biofabrication, September 2023, Institute of Physics Publishing

    Dr Margarita M Ivanova

  8. Circulated TGF-β1 and VEGF-A as Biomarkers for Fabry Disease-Associated Cardiomyopathy

    Article • Cells, August 2023, MDPI AG

    Dr Margarita M Ivanova

  9. Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease

    Article • Frontiers in Endocrinology, November 2022, Frontiers

    Dr Margarita M Ivanova

  10. Editorial: Sphingolipid metabolism and cancer

    Article • Frontiers in Oncology, November 2022, Frontiers

    Dr Margarita M Ivanova

  11. Identification of circulated biomarkers in Fabry disease patients associated with hypertrophic cardiomyopathy

    Article • Molecular Genetics and Metabolism, February 2022, Elsevier

    Dr Margarita M Ivanova

  12. Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease

    Article • PLOS One, October 2021, PLOS

    Dr Margarita M Ivanova

  13. TRAP5b and RANKL/OPG Predict Bone Pathology in Patients with Gaucher Disease

    Article • Journal of Clinical Medicine, May 2021, MDPI AG

    Dr Margarita M Ivanova

  14. TRAP5b and RANKL/OPG Predict Bone Pathology in Patients with Gaucher disease

    Article • April 2021, MDPI AG

    Dr Margarita M Ivanova

  15. Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease

    Article • February 2021, Cold Spring Harbor Laboratory Press

    Dr Margarita M Ivanova

  16. Selective screening for lysosomal storage disorders in a large cohort of minorities of African descent shows high prevalence rates and novel variants

    Article • JIMD Reports, January 2021, Wiley

    Dr Margarita M Ivanova

  17. Rapid Clathrin-Mediated Uptake of Recombinant α-Gal-A to Lysosome Activates Autophagy

    Article • Biomolecules, May 2020, MDPI AG

    Dr Margarita M Ivanova

  18. Altered Sphingolipids Metabolism Damaged Mitochondrial Functions: Lessons Learned From Gaucher and Fabry Diseases

    Article • Journal of Clinical Medicine, April 2020, MDPI AG

    Dr Margarita M Ivanova

  19. Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases

    Article • PLOS One, January 2019, PLOS

    Dr Margarita M Ivanova

  20. Gaucheromas: When macrophages promote tumor formation and dissemination

    Article • Blood Cells Molecules and Diseases, February 2018, Elsevier

    Dr Margarita M Ivanova

  21. Nuclear respiratory factor-1 and bioenergetics in tamoxifen-resistant breast cancer cells

    Article • Experimental Cell Research, September 2016, Elsevier

    Dr Margarita M Ivanova

  22. Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease

    Article • Blood Cells Molecules and Diseases, July 2016, Elsevier

    Dr Margarita M Ivanova

  23. Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells

    Article • Journal of Biological Chemistry, June 2015, Elsevier

    Dr Margarita M Ivanova

  24. Soy glyceollins regulate transcript abundance in the female mouse brain

    Article • Functional & Integrative Genomics, May 2015, Springer Science + Business Media

    Dr Margarita M Ivanova

  25. Bioenergetic differences between MCF-7 and T47D breast cancer cells and their regulation by oestradiol and tamoxifen

    Article • Biochemical Journal, December 2014, Portland Press Ltd.

    Dr Margarita M Ivanova

  26. Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor

    Article • Molecular and Cellular Endocrinology, July 2014, Elsevier

    Dr Margarita M Ivanova

  27. 5-Aza-2-deoxycytidine and trichostatin A increase COUP-TFII expression in antiestrogen-resistant breast cancer cell lines

    Article • Cancer Letters, May 2014, Elsevier

    Dr Margarita M Ivanova

  28. β-D-glucan inhibits endocrine-resistant breast cancer cell proliferation and alters gene expression

    Article • International Journal of Oncology, February 2014, Spandidos Publications

    Dr Margarita M Ivanova

  29. Estradiol and tamoxifen regulate NRF-1 and mitochondrial function in mouse mammary gland and uterus

    Article • July 2013, Bioscientifica

    Carolyn Klinge, Dr Margarita M Ivanova

  30. Effect of nonpersistent pesticides on estrogen receptor, androgen receptor, and aryl hydrocarbon receptor

    Article • Environmental Toxicology, February 2013, Wiley

    Dr Margarita M Ivanova

  31. DHEA metabolites activate estrogen receptors alpha and beta

    Article • Steroids, January 2013, Elsevier

    Dr Margarita M Ivanova

  32. Identification and Characterization of Nucleolin as a COUP-TFII Coactivator of Retinoic Acid Receptor β Transcription in Breast Cancer Cells

    Article • PLOS One, May 2012, PLOS

    Dr Alyson M Hockenberry, Dr Margarita M Ivanova

  33. Targeting the Intracellular MUC1 C-terminal Domain Inhibits Proliferation and Estrogen Receptor Transcriptional Activity in Lung Adenocarcinoma Cells

    Article • Molecular Cancer Therapeutics, November 2011, American Association for Cancer Research (AACR)

    Dr Margarita M Ivanova

  34. Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses

    Article • Proteome Science, September 2011, Springer Science + Business Media

    Dr Margarita M Ivanova

  35. Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor β and AP‐1 recruitment to adjacent promoter binding sites

    Article • The FASEB Journal, January 2011, Wiley

    Dr Margarita M Ivanova

  36. Anacardic Acid Inhibits Estrogen Receptor α–DNA Binding and Reduces Target Gene Transcription and Breast Cancer Cell Proliferation

    Article • Molecular Cancer Therapeutics, March 2010, American Association for Cancer Research (AACR)

    Dr Margarita M Ivanova

  37. Sex Differences in Estrogen Receptor Subcellular Location and Activity in Lung Adenocarcinoma Cells

    Article • American Journal of Respiratory Cell and Molecular Biology, March 2010, American Thoracic Society

    Dr Margarita M Ivanova

  38. Activity and intracellular location of estrogen receptors α and β in human bronchial epithelial cells

    Article • Molecular and Cellular Endocrinology, June 2009, Elsevier

    Dr Margarita M Ivanova

  39. Estradiol Stimulates Transcription of Nuclear Respiratory Factor-1 and Increases Mitochondrial Biogenesis

    Article • Molecular Endocrinology, March 2008, Endocrine Society

    Dr Margarita M Ivanova

  40. Resveratrol stimulates nitric oxide production by increasing estrogen receptor αa‐Src‐caveolin‐1 interaction and phosphorylation in human umbilical vein endothelial cells

    Article • The FASEB Journal, February 2008, Wiley

    Dr Margarita M Ivanova

  41. Rapid effects of diesel exhaust particulate extracts on intracellular signaling in human endothelial cells

    Article • Toxicology Letters, November 2007, Elsevier

    Dr Margarita M Ivanova

  42. Estrogen receptor beta yield from baculovirus lytic infection is higher than from stably transformed Sf21 cells

    Article • Applied Microbiology and Biotechnology, April 2007, Springer Science + Business Media

    Dr Margarita M Ivanova

  43. Effects of estradiol and 4-hydroxytamoxifen on the conformation, thermal stability, and DNA recognition of estrogen receptor β

    Article • Biochemistry and Cell Biology, February 2007, Canadian Science Publishing

    Dr Margarita M Ivanova

  44. Effect of estradiol and dihydrotestosterone on hypergravity-induced MAPK signaling and occludin expression in human umbilical vein endothelial cells

    Article • Cell and Tissue Research, January 2006, Springer Science + Business Media

    Dr Margarita M Ivanova

  45. Developmental expression and function of aldehyde reductase in proximal tubules of the kidney

    Article • AJP Renal Physiology, July 2005, American Physiological Society

    Dr Margarita M Ivanova

  46. Scaffold Attachment Factor B1 Functions in Development, Growth, and Reproduction

    Article • Molecular and Cellular Biology, April 2005, ASM Journals

    Dr Margarita M Ivanova

  47. Developmental and Hormonal Signals Dramatically Alter the Localization and Abundance of Insulin Receptor Substrate Proteins in the Mammary Gland

    Article • Endocrinology, June 2003, Endocrine Society

    Dr Margarita M Ivanova

  48. Receptor-mediated transport of foreign DNA into preimplantation mammalian embryos

    Article • Molecular Reproduction and Development, October 1999, Wiley

    Professor Alexander S. Sobolev, Dr Margarita M Ivanova